Appropriate use of complementary and alternative medicine approaches in gynecologic cancers

Dana M. Chase, Steven J. Gibson, Daniele A. Sumner, Jennifer W Bea, David S Alberts

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Gynecologic cancer patients frequently desire alternative and/or complementary interventions or medicines to aid in relief of both cancer-related and treatment-related side effects. Furthermore, women also seek treatment to aid in superior outcomes and cure rates. Unfortunately, evidence suggests that the use of complementary and/or alternative medicine (CAM) is underreported or not discussed with physicians providing cancer care. In gynecologic cancer literature, there is a lack of scientific evidence either supporting or negating CAM. Because of the lack of information available, health care providers do not have good information regarding safety, efficacy, and dose of CAM. This leads to miscommunication or absence of communication between providers and patients. Because patients do use CAM to improve quality of life (QOL) during and after treatment, it would be educational for providers to know the specific QOL deficits among patients that require attention. Thus, with the ultimate goal of improving QOL for gynecologic cancer patients, providers should be pushed to investigate CAM and determine an honest support or rejection of these therapies.

Original languageEnglish (US)
Pages (from-to)14-26
Number of pages13
JournalCurrent Treatment Options in Oncology
Volume15
Issue number1
DOIs
StatePublished - 2014

Fingerprint

Complementary Therapies
Neoplasms
Quality of Life
Second Primary Neoplasms
Health Personnel
Therapeutics
Communication
Physicians
Safety

Keywords

  • Alternative medicine
  • Cervical cancer
  • Complementary medicine
  • Gynecologic cancer
  • Ovarian cancer

ASJC Scopus subject areas

  • Oncology
  • Pharmacology (medical)

Cite this

Appropriate use of complementary and alternative medicine approaches in gynecologic cancers. / Chase, Dana M.; Gibson, Steven J.; Sumner, Daniele A.; Bea, Jennifer W; Alberts, David S.

In: Current Treatment Options in Oncology, Vol. 15, No. 1, 2014, p. 14-26.

Research output: Contribution to journalArticle

@article{57376010fd8c4b09ab062abc2035e308,
title = "Appropriate use of complementary and alternative medicine approaches in gynecologic cancers",
abstract = "Gynecologic cancer patients frequently desire alternative and/or complementary interventions or medicines to aid in relief of both cancer-related and treatment-related side effects. Furthermore, women also seek treatment to aid in superior outcomes and cure rates. Unfortunately, evidence suggests that the use of complementary and/or alternative medicine (CAM) is underreported or not discussed with physicians providing cancer care. In gynecologic cancer literature, there is a lack of scientific evidence either supporting or negating CAM. Because of the lack of information available, health care providers do not have good information regarding safety, efficacy, and dose of CAM. This leads to miscommunication or absence of communication between providers and patients. Because patients do use CAM to improve quality of life (QOL) during and after treatment, it would be educational for providers to know the specific QOL deficits among patients that require attention. Thus, with the ultimate goal of improving QOL for gynecologic cancer patients, providers should be pushed to investigate CAM and determine an honest support or rejection of these therapies.",
keywords = "Alternative medicine, Cervical cancer, Complementary medicine, Gynecologic cancer, Ovarian cancer",
author = "Chase, {Dana M.} and Gibson, {Steven J.} and Sumner, {Daniele A.} and Bea, {Jennifer W} and Alberts, {David S}",
year = "2014",
doi = "10.1007/s11864-013-0269-x",
language = "English (US)",
volume = "15",
pages = "14--26",
journal = "Current Treatment Options in Oncology",
issn = "1527-2729",
publisher = "Springer New York",
number = "1",

}

TY - JOUR

T1 - Appropriate use of complementary and alternative medicine approaches in gynecologic cancers

AU - Chase, Dana M.

AU - Gibson, Steven J.

AU - Sumner, Daniele A.

AU - Bea, Jennifer W

AU - Alberts, David S

PY - 2014

Y1 - 2014

N2 - Gynecologic cancer patients frequently desire alternative and/or complementary interventions or medicines to aid in relief of both cancer-related and treatment-related side effects. Furthermore, women also seek treatment to aid in superior outcomes and cure rates. Unfortunately, evidence suggests that the use of complementary and/or alternative medicine (CAM) is underreported or not discussed with physicians providing cancer care. In gynecologic cancer literature, there is a lack of scientific evidence either supporting or negating CAM. Because of the lack of information available, health care providers do not have good information regarding safety, efficacy, and dose of CAM. This leads to miscommunication or absence of communication between providers and patients. Because patients do use CAM to improve quality of life (QOL) during and after treatment, it would be educational for providers to know the specific QOL deficits among patients that require attention. Thus, with the ultimate goal of improving QOL for gynecologic cancer patients, providers should be pushed to investigate CAM and determine an honest support or rejection of these therapies.

AB - Gynecologic cancer patients frequently desire alternative and/or complementary interventions or medicines to aid in relief of both cancer-related and treatment-related side effects. Furthermore, women also seek treatment to aid in superior outcomes and cure rates. Unfortunately, evidence suggests that the use of complementary and/or alternative medicine (CAM) is underreported or not discussed with physicians providing cancer care. In gynecologic cancer literature, there is a lack of scientific evidence either supporting or negating CAM. Because of the lack of information available, health care providers do not have good information regarding safety, efficacy, and dose of CAM. This leads to miscommunication or absence of communication between providers and patients. Because patients do use CAM to improve quality of life (QOL) during and after treatment, it would be educational for providers to know the specific QOL deficits among patients that require attention. Thus, with the ultimate goal of improving QOL for gynecologic cancer patients, providers should be pushed to investigate CAM and determine an honest support or rejection of these therapies.

KW - Alternative medicine

KW - Cervical cancer

KW - Complementary medicine

KW - Gynecologic cancer

KW - Ovarian cancer

UR - http://www.scopus.com/inward/record.url?scp=84894663649&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84894663649&partnerID=8YFLogxK

U2 - 10.1007/s11864-013-0269-x

DO - 10.1007/s11864-013-0269-x

M3 - Article

C2 - 24398574

AN - SCOPUS:84894663649

VL - 15

SP - 14

EP - 26

JO - Current Treatment Options in Oncology

JF - Current Treatment Options in Oncology

SN - 1527-2729

IS - 1

ER -